Biomaterial Applications in Cardiovascular Tissue Repair And regeneration

Overview

Journal Expert Rev Cardiovasc Ther

Specialty Cardiology & Vascular Diseases

Date 2012 Oct 4

PMID 23030293

Citations 51

Authors

Mai T Lam

Joseph C Wu

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease physically damages the heart, resulting in loss of cardiac function. Medications can help alleviate symptoms, but it is more beneficial to treat the root cause by repairing injured tissues, which gives patients better outcomes. Besides heart transplants, cardiac surgeons use a variety of methods for repairing different areas of the heart such as the ventricular septal wall and valves. A multitude of biomaterials are used in the repair and replacement of impaired heart tissues. These biomaterials fall into two main categories: synthetic and natural. Synthetic materials used in cardiovascular applications include polymers and metals. Natural materials are derived from biological sources such as human donor or harvested animal tissues. A new class of composite materials has emerged to take advantage of the benefits of the strengths and minimize the weaknesses of both synthetic and natural materials. This article reviews the current and prospective applications of biomaterials in cardiovascular therapies.

Citing Articles

Cardiovascular patches applied in congenital cardiac surgery: Current materials and prospects.

Sun M, LaSala V, Giuglaris C, Blitzer D, Jackman S, Ustunel S Bioeng Transl Med. 2025; 10(1):e10706.

PMID: 39801761 PMC: 11711229. DOI: 10.1002/btm2.10706.

Tissue engineered decellularized bovine pericardium as prosthetic material in paediatric cardiac surgery.

Tiwari N, Kumar A, Ramamurthy H, Kumar V, Khare A Indian J Thorac Cardiovasc Surg. 2024; 41(1):35-40.

PMID: 39679085 PMC: 11638438. DOI: 10.1007/s12055-024-01769-8.

An Evaluation of the Treatment of Full-Thickness Wounds Using Adipose Micro-Fragments within a Liquid Dermal Scaffold.

Sheikh-Oleslami S, Hassanpour I, Amiri N, Jalili R, Kilani R, Ghahary A Eur Burn J. 2024; 3(3):457-471.

PMID: 39599959 PMC: 11571836. DOI: 10.3390/ebj3030040.

Numerical modeling and analysis of cardiac stent using blood hammer principle.

R S, S H, Karnan H, V K, V A Technol Health Care. 2024; 32(6):4223-4238.

PMID: 39093086 PMC: 11613089. DOI: 10.3233/THC-240051.

Enhancing Dental Material Performance: Tung Oil-Infused Polyurea Microcapsule Coatings for Self-Healing and Antimicrobial Applications.

Zhong J, Hu Y, Wang D, Zhou X, Yuan P, Luo B Polymers (Basel). 2024; 16(7).

PMID: 38611176 PMC: 11013920. DOI: 10.3390/polym16070918.

References

Shayani V, Newman K, Dichek D . Optimization of recombinant t-PA secretion from seeded vascular grafts. J Surg Res. 1994; 57(4):495-504. DOI: 10.1006/jsre.1994.1175. View

Law K, Phillips K, Butany J . Pulmonary valve-in-valve implants: how long do they prolong reintervention and what causes them to fail?. Cardiovasc Pathol. 2012; 21(6):519-21. DOI: 10.1016/j.carpath.2012.02.010. View

Liao K, Seifter E, Hoffman D, Yellin E, Frater R . Bovine pericardium versus porcine aortic valve: comparison of tissue biological properties as prosthetic valves. Artif Organs. 1992; 16(4):361-5. DOI: 10.1111/j.1525-1594.1992.tb00532.x. View

Miyazaki T, Yamagishi M, Nakashima A, Fukae K, Nakano T, Yaku H . Expanded polytetrafluoroethylene valved conduit and patch with bulging sinuses in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg. 2007; 134(2):327-32. DOI: 10.1016/j.jtcvs.2007.03.030. View

Chiu L, Janic K, Radisic M . Engineering of oriented myocardium on three-dimensional micropatterned collagen-chitosan hydrogel. Int J Artif Organs. 2012; 35(4):237-50. DOI: 10.5301/ijao.5000084. View

Ruvinov E, Harel-Adar T, Cohen S . Bioengineering the infarcted heart by applying bio-inspired materials. J Cardiovasc Transl Res. 2011; 4(5):559-74. DOI: 10.1007/s12265-011-9288-9. View

OBrien B, Stinson J, Larsen S, Eppihimer M, Carroll W . A platinum-chromium steel for cardiovascular stents. Biomaterials. 2010; 31(14):3755-61. DOI: 10.1016/j.biomaterials.2010.01.146. View

Konertz W, Angeli E, Tarusinov G, Christ T, Kroll J, Dohmen P . Right ventricular outflow tract reconstruction with decellularized porcine xenografts in patients with congenital heart disease. J Heart Valve Dis. 2011; 20(3):341-7. View

Simpson D, Liu H, Fan T, Nerem R, Dudley Jr S . A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007; 25(9):2350-7. PMC: 3158658. DOI: 10.1634/stemcells.2007-0132. View

10.

Eschenhagen T, Eder A, Vollert I, Hansen A . Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol. 2012; 303(2):H133-43. DOI: 10.1152/ajpheart.00007.2012. View

11.

Goissis G, Giglioti A, Braile D . Preparation and characterization of an acellular bovine pericardium intended for manufacture of valve bioprostheses. Artif Organs. 2011; 35(5):484-9. DOI: 10.1111/j.1525-1594.2011.01264.x. View

12.

Aumsuwan N, Ye S, Wagner W, Urban M . Covalent attachment of multilayers on poly(tetrafluoroethylene) surfaces. Langmuir. 2011; 27(17):11106-10. DOI: 10.1021/la201957a. View

13.

Nguyen P, Lan F, Wang Y, Wu J . Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res. 2011; 109(8):962-79. PMC: 3206967. DOI: 10.1161/CIRCRESAHA.111.242909. View

14.

Cashman T, Gouon-Evans V, Costa K . Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms. Stem Cell Rev Rep. 2012; 9(3):254-65. PMC: 5868420. DOI: 10.1007/s12015-012-9375-6. View

15.

McGregor C, Carpentier A, Lila N, Logan J, Byrne G . Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg. 2010; 141(1):269-75. DOI: 10.1016/j.jtcvs.2010.08.064. View

16.

Frederick J, Fitzpatrick 3rd J, McCormick R, Harris D, Kim A, Muenzer J . Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation. 2010; 122(11 Suppl):S107-17. PMC: 4156010. DOI: 10.1161/CIRCULATIONAHA.109.930404. View

17.

Zhao Z, Puskas J, Xu D, Wang N, Mosunjac M, Guyton R . Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol. 2010; 55(12):1250-1261. DOI: 10.1016/j.jacc.2009.10.049. View

18.

Karam J, Muscari C, Montero-Menei C . Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials. 2012; 33(23):5683-95. DOI: 10.1016/j.biomaterials.2012.04.028. View

19.

Yashiro B, Shoda M, Tomizawa Y, Manaka T, Hagiwara N . Long-term results of a cardiovascular implantable electronic device wrapped with an expanded polytetrafluoroethylene sheet. J Artif Organs. 2012; 15(3):244-9. DOI: 10.1007/s10047-012-0634-8. View

20.

Jensen N, Lindblad B, Bergqvist D . Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J Cardiovasc Surg (Torino). 1994; 35(5):425-9. View